TITLE from VIEW and SLIDE MASTER | August 7, 2015 1 |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *

Slides:

Advertisements

Similar presentations

EMR Intercountry Workshop, December |1 | VP-IBD Surveillance Data, 2009 Photo: Dr. Mary Agócs.

Advertisements

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.

1 |1 | Countries using and planning to introduce IPV.

Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

Vaccine in National Immunization Programme Update March 2015.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

World Health Organization

1 |1 | Countries using and planning to introduce IPV.

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

World Health Organization

1 |1 | Countries using and planning to introduce IPV.

Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.

Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.

A program of the THE GLOBAL VACCINE ACTION PLAN SHAPING IMMUNIZATION PROGRAMMES IN THE CURRENT DECADE Thomas Cherian Department of Immunization, Vaccines.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.

1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.

The changing vaccination landscape and the sources of vaccination data

Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.

1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration.

1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration.

Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.

1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.

Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.

Vaccine in National Immunization Programme Update April 2016.

World Health Organization

SAGE 2010 Sampling Distribution

2016 Immunization Coverage Data at Subnational Level

reporting rate of discarded cases* per 100'000 population**

World Health Organization

Session 1: New Opportunities and New Direction

World Health Organization

Monthly Distribution of Wild Poliovirus Cases1,

SAGE 2009 Sampling Distribution

World Health Organization

06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries Having Introduced Hib Vaccine

Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010

Sampling Distribution

Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016

Monthly Distribution of Wild Poliovirus Cases1,

(70 countries or 36%) (23 countries or 12%)

Countries with Genotype data available

Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.

World Health Organization

World Health Organization

Onset of most recent WPV1 Case Number of WPV infected districts

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries having introduced HepB vaccine

No new positives this week

05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Most-affected regions in the Russian Federation

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

Mapping Levels of Palliative Care Development: A Global Update

Countries Using Mening Vaccine in National Immunization Schedule 2011

- Use same categories as for bar chart below Introduced Without GAVI

Onset of most recent case Number of infected districts

04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.

Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.

16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)

World Health Organization

World Health Organization

Attachment B-3: Animation of 137Cs deposition on ground/sea surface

World Health Organization

Presentation transcript:

TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions * Includes partial introduction The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Data Source: WHO/IVB Database, as at 23 June 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 23 June 2014 Not Available, Not Introduced /No Plans (2 countries or 1%) Not applicable Planned introductions in 2014 (2 countries or 1%) Introduced* to date ( 190 countries or 98%)

TITLE from VIEW and SLIDE MASTER | August 7, |2 | The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2014 * Includes partial introduction Data Source: WHO/IVB Database, as at 23 June 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 23 June 2014 Not Available, Not Introduced /No Plans (74 countries or 38%) Not applicable Planned introductions in 2014 (11 countries or 6%) Introduced* to date (109 countries or 56%)

TITLE from VIEW and SLIDE MASTER | August 7, |3 | The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Countries with Rotavirus vaccine in the national immunization programme; and planned introductions for 2014 * Includes partial introduction Data Source: WHO/IVB Database, as at 04 July 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 04 July 2014 Not Available, Not Introduced /No Plans (122 countries or 63%) Not applicable Planned introductions in 2014 (6 countries or 3%) Introduced* to date ( 66 countries or 34%)

TITLE from VIEW and SLIDE MASTER | August 7, |4 | The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Countries with HPV vaccine in the national immunization programme Data Source: WHO/IVB Database, as at 23 June 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 30 June 2014 Not Available, Not Introduced /No Plans (136 countries or 70%) Not applicable Introduced* to date ( 58 countries or 30%) * Includes partial introduction

TITLE from VIEW and SLIDE MASTER | August 7, |5 | The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Countries/Territories using Yellow Fever* vaccine to date Data Source: WHO/IVB Database, as at 06 February 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 14 March 2014 Not Available / Not At risk (147 countries or 76%) Not applicable At risk but not Introduced (11 countries or 23%) Introduced in High risk areas (4 countries or 8% ) Introduced to date (33 countries or 69%) * WHO considers that 48 countries/Territories are at risk for YF

TITLE from VIEW and SLIDE MASTER | August 7, |6 | The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Countries using IPV vaccine to date Data Source: WHO/IVB Database, as at 02 June 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 2 June 2014 Not Available, Not Introduced /No Plans (122 countries or 63%) Not applicable Introduced to date (72 countries or 37%)

TITLE from VIEW and SLIDE MASTER | August 7, |7 | The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Countries and Territories using JE vaccine to date Data Source: WHO/IVB Database, as at 26 March 2014 and International travel Health Database ( Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 26 March 2014 Not applicable Introduced in parts of the country (5 countries or 22% ) Introduced to date (6 countries or 26%) At risk but not introduced (12 countries or 52%) * WHO considers that 23 countries/Territories are at risk for JE

TITLE from VIEW and SLIDE MASTER | August 7, |8 | The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Countries using Measles Second Dose vaccine to date; and planned introductions Data Source: WHO/IVB Database, as at 04 July 2014 Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 04 July 2014 Not Available, Not Introduced /No Plans (39 countries or 20%) Not applicable Planned introductions in 2014 (5 countries or 3%) Introduced to date ( 150 countries or 77%)

TITLE from VIEW and SLIDE MASTER | August 7, |9 | Distribution of countries using rubella vaccine in their routine immunization schedule in 2013 and countries planning introduction during The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved Data Source: Source: WHO/Expanded Programme on Immunization, as at 1 July WHO Member States Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization Date of slide: 04 July 2014 Rubella vaccine not in the routine schedule or planned before 2015 or data not available (46 countries or 24%) Not applicable I ntroduction planned (11 countries or 6%) Introduced prior to 2013 (137 countries or 71%)